Mabpharm Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 36.59 | -100% | -17.27 | -100% |
| P/S |
|
20.78 | 7.13 | 191.25% |
|
|
| P/BV |
|
9.71 | 3.66 | 165.69% |
|
|
| P/FCF |
|
72.1 | -11.82 | -710.22% |
|
|
| Ev/Ebitda |
|
-10.86 | 2.91 | -473.55% |
|
|
| Ev/S |
|
21.12 | 16.44 | 28.51% |
|
|
| Ev/FCF |
|
47.99 | -7.89 | -708.51% |
|
|
| E/P |
|
-0.0757 | 0.0325 | -333.19% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-169.72 | -9.7 | 1649.61% | -406.54 | -58.25% |
| ROE |
|
-77.47 | 4.42 | -1853.19% |
|
|
| ROA |
|
-23.91 | 2.95 | -910.76% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-240.27 | -11.15 | 2055.25% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.05 | 0.7677 | -236.81% | -0.9002 | +16.67% |
| Nеt Debt/Ebitda |
|
-0.2238 | 0.0174 | -1388.41% |
|
|
| Debt/Ratio |
|
0.165 | 0.1212 | 36.13% |
|
|
| Debt/Equity |
|
0.7847 | 0.8042 | -2.43% |
|
|
| Debt/Net Income |
|
-0.7419 | 1.54 | -148.27% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.13 | -100% | ||
| DSI |
|
0 | 0.5838 | -100% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 4.95 | -100% |
|
|
| Average percentage for payments |
|
0 | 24.82 | -100% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1889.34 | 1.85 | 102026.49% | ||
| Growth impulse Ebitda in 5 years |
|
-3.71 | -44.43 | -91.65% | ||
| Growth impulse Net Income in 5 years |
|
10.65 | 58.07 | -81.66% | ||
| Growth impulse FCF in 5 years |
|
-116.39 | -7.48 | 1456.02% | ||
| Growth impulse EPS in 5 years |
|
944.23 | -198.43 | -575.85% |
IP Score
3.19/10
